The good, the bad and the COVID: BioCentury’s playlist for pandemic times 

Saying goodbye to a grueling year, BioCentury editors have furrowed among the disasters to pick out some of the positives from 2020, and call out some of the worst of the pandemic’s collateral damage. Then they put their goggles on for where the sun might shine in 2021. 

Simone Fishburn, Editor in Chief 
Master protocols proved their worth and diagnostics finally got some respect, with PCR and antigen testing becoming household terms. Data-sharing inched forward,  and the biopharma industry showed the world the value of its day job. Meanwhile, less travel yielded a better carbon footprint, not to mention less jet-lag, though not more sleep...